06.14.25 -- Cell & Gene Best Of May

With pressure to both accelerate development and prioritize robustness, CGT companies often have limited time for refining manufacturing, analytics, and logistics. Enter the Cell & Gene Therapy Tech Expo: a dynamic slate of industry-leading suppliers showcasing the latest in solutions across Cell Therapy, Gene Therapy, and GMP/Regulatory Compliance via 15-minute interactive presentations. Register for free and make continuous improvement a reality on your path to scalability, cost reduction and, ultimately, enhanced patient access.

Making the right outsourcing decision can significantly contribute to the success and growth of your program, providing support and resources that empower it to thrive in its objectives and endeavors.

The debate over whether to pay donors for cell therapy starting materials comes down to four areas of disagreement: altruism, availability, ethics, and safety.

For all its patient-centered benefits, producing personalized medicine at the point of care has pitfalls that are worth careful consideration.

Explore the complexities of immunogenicity assessment in gene therapy development that focuses on regulatory frameworks in the US and EU, and gain insight into the best practices for global compliance.

Conducting multi-regional clinical trials (MRCTs) is essential for accelerating oncology drug development and ensuring broader patient access. However, differences across regions can impact findings.

Hear from a 21 CFR Part 11 expert with nearly 20 years of experience supporting pharmaceutical and medical device companies with implementing solutions and systems to ensure compliance.